Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3486001 | 0.70 | FOLH1 (0.34) | — | |
| Phosphoric Acid SCHEMBL3485697 | 0.65 | MEN1 (0.33) | MEN1ALDH1A1KMT2A | |
| SCHEMBL3485667 | 0.61 | — | — | |
| SCHEMBL668855 | 0.61 | FDPS (0.40) | — | |
| SCHEMBL3484882 | 0.57 | FDPS (0.32) | — | |
| SCHEMBL10887892 | 0.54 | FDPS (0.33) | — | |
| SCHEMBL7168800 | 0.50 | — | — | |
| Pyrophosphoric Acid SCHEMBL8851914 | 0.46 | FDPS (1.00) | — | |
| Pyrophosphoric Acid SCHEMBL292348 | 0.46 | FDPS (1.00) | — | |
| SCHEMBL309434 | 0.46 | FDPS (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2010-02-04 | — | — | US | claimed |
| EP-1828217-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | Febit Biotech GmbH (DE) | 2007-09-05 | — | — | EP | claimed |
| WO-2006063717-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2006-06-22 | — | — | WO | claimed |
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2010-02-04 | — | — | US | disclosed |
| EP-1828217-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | Febit Biotech GmbH (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006063717-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | POLB, POLM, POLN | MEN1 4602/4885ALDH1A1 4173/4885KMT2A 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.